Atlas Trials

Akesobio Australia Pty Ltd

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Akesobio Australia Pty Ltd

RecordFirmDate
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours (NCT05021120)Akesobio Australia Pty Ltd2021-10-12
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis (NCT05048056)Akesobio Australia Pty Ltd2021-09-30
A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects (NCT04516564)Akesobio Australia Pty Ltd2020-09-28
A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis (NCT04256174)Akesobio Australia Pty Ltd2020-06-15
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104 (NCT04349969)Akesobio Australia Pty Ltd2020-04-23
A Study of AK111 in Healthy Subjects (NCT03622021)Akesobio Australia Pty Ltd2018-08-14
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors (NCT03352531)Akesobio Australia Pty Ltd2018-01-02
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors (NCT03261011)Akesobio Australia Pty Ltd2017-10-03

Track Akesobio Australia Pty Ltd automatically

Every clearance here is in the API, with alerts when new ones post.